Flt3 ligand-treated neonatal mice have increased innate immunity against intracellular pathogens and efficiently control virus infections
Flt-3 ligand (FL), a hematopoetic growth factor, increases the number of dendritic cells (DCs), B cells, and natural killer cells in adult mice but the effect in neonates was unknown. We show that FL treatment of newborn mice induced a >100-fold increase in the innate resistance against infection...
Uložené v:
| Vydané v: | The Journal of experimental medicine Ročník 197; číslo 5; s. 575 |
|---|---|
| Hlavní autori: | , , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
United States
03.03.2003
|
| Predmet: | |
| ISSN: | 0022-1007 |
| On-line prístup: | Zistit podrobnosti o prístupe |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Abstract | Flt-3 ligand (FL), a hematopoetic growth factor, increases the number of dendritic cells (DCs), B cells, and natural killer cells in adult mice but the effect in neonates was unknown. We show that FL treatment of newborn mice induced a >100-fold increase in the innate resistance against infection with herpes simplex virus type 1 and Listeria monocytogenes. This resistance required interferon (IFN)-alpha/beta for viral and interleukin (IL)-12 for bacterial infections. Long-term survival after viral but not bacterial infection was increased approximately 100-fold by FL treatment. After treatment, CD11c(+)/major histocompatibility complex type II(+) and CD11c(+)/B220(+) DC lineage cells were the only cell populations increased in the spleen, liver, peritoneum, and skin. DC induction was independent of IFNs, IL-2, -4, -7, -9, -15, and mature T and B cells. The data suggest that FL increases the number of DCs in neonates and possibly in other immune-compromised individuals, which in turn improves IFN-alpha/beta- and IL-12-associated immune responses. |
|---|---|
| AbstractList | Flt-3 ligand (FL), a hematopoetic growth factor, increases the number of dendritic cells (DCs), B cells, and natural killer cells in adult mice but the effect in neonates was unknown. We show that FL treatment of newborn mice induced a >100-fold increase in the innate resistance against infection with herpes simplex virus type 1 and Listeria monocytogenes. This resistance required interferon (IFN)-alpha/beta for viral and interleukin (IL)-12 for bacterial infections. Long-term survival after viral but not bacterial infection was increased approximately 100-fold by FL treatment. After treatment, CD11c(+)/major histocompatibility complex type II(+) and CD11c(+)/B220(+) DC lineage cells were the only cell populations increased in the spleen, liver, peritoneum, and skin. DC induction was independent of IFNs, IL-2, -4, -7, -9, -15, and mature T and B cells. The data suggest that FL increases the number of DCs in neonates and possibly in other immune-compromised individuals, which in turn improves IFN-alpha/beta- and IL-12-associated immune responses. Flt-3 ligand (FL), a hematopoetic growth factor, increases the number of dendritic cells (DCs), B cells, and natural killer cells in adult mice but the effect in neonates was unknown. We show that FL treatment of newborn mice induced a >100-fold increase in the innate resistance against infection with herpes simplex virus type 1 and Listeria monocytogenes. This resistance required interferon (IFN)-alpha/beta for viral and interleukin (IL)-12 for bacterial infections. Long-term survival after viral but not bacterial infection was increased approximately 100-fold by FL treatment. After treatment, CD11c(+)/major histocompatibility complex type II(+) and CD11c(+)/B220(+) DC lineage cells were the only cell populations increased in the spleen, liver, peritoneum, and skin. DC induction was independent of IFNs, IL-2, -4, -7, -9, -15, and mature T and B cells. The data suggest that FL increases the number of DCs in neonates and possibly in other immune-compromised individuals, which in turn improves IFN-alpha/beta- and IL-12-associated immune responses.Flt-3 ligand (FL), a hematopoetic growth factor, increases the number of dendritic cells (DCs), B cells, and natural killer cells in adult mice but the effect in neonates was unknown. We show that FL treatment of newborn mice induced a >100-fold increase in the innate resistance against infection with herpes simplex virus type 1 and Listeria monocytogenes. This resistance required interferon (IFN)-alpha/beta for viral and interleukin (IL)-12 for bacterial infections. Long-term survival after viral but not bacterial infection was increased approximately 100-fold by FL treatment. After treatment, CD11c(+)/major histocompatibility complex type II(+) and CD11c(+)/B220(+) DC lineage cells were the only cell populations increased in the spleen, liver, peritoneum, and skin. DC induction was independent of IFNs, IL-2, -4, -7, -9, -15, and mature T and B cells. The data suggest that FL increases the number of DCs in neonates and possibly in other immune-compromised individuals, which in turn improves IFN-alpha/beta- and IL-12-associated immune responses. |
| Author | Vollstedt, Sabine Riesen, Matthias Suter, Mark Ackermann, Mathias Franchini, Marco O'Keeffe, Meredith Glanzmann, Bettina Odermatt, Bernhard Hefti, Hans P Alber, Gottfried |
| Author_xml | – sequence: 1 givenname: Sabine surname: Vollstedt fullname: Vollstedt, Sabine organization: Institute of Virology, University of Zurich, 8057 Zurich, Switzerland – sequence: 2 givenname: Marco surname: Franchini fullname: Franchini, Marco – sequence: 3 givenname: Hans P surname: Hefti fullname: Hefti, Hans P – sequence: 4 givenname: Bernhard surname: Odermatt fullname: Odermatt, Bernhard – sequence: 5 givenname: Meredith surname: O'Keeffe fullname: O'Keeffe, Meredith – sequence: 6 givenname: Gottfried surname: Alber fullname: Alber, Gottfried – sequence: 7 givenname: Bettina surname: Glanzmann fullname: Glanzmann, Bettina – sequence: 8 givenname: Matthias surname: Riesen fullname: Riesen, Matthias – sequence: 9 givenname: Mathias surname: Ackermann fullname: Ackermann, Mathias – sequence: 10 givenname: Mark surname: Suter fullname: Suter, Mark |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/12615899$$D View this record in MEDLINE/PubMed |
| BookMark | eNo1kD9PwzAQxT0U0T-wMSNPbCm248TxiCoKSJVYYK4uzqV15Tgldir1I_CtMaJMd3q_d093NycT33sk5I6zJWeVfDxgtxSMCa4Zm5BZ6kTGGVNTMg_hwBiXsiivyZSLkheV1jPyvXYxp87uwDdZHBAiNtRj7yGCo501SPdwQmq9STAkaH1iSei60dt4prAD60NMehzAoHOjg4EeIe77HfpAUzDFtrXGoo_uTE2fjL2jJzuMIU21aKLtfbghVy24gLeXuiCf6-eP1Wu2eX95Wz1tMiOVipmqsNGlMqUCzRmqXBYt121eqlYbFBwrKVVR55VC3phW1LphhamZBDC1NKVYkIe_3OPQf40Y4raz4XdvSGePYatypnjJ82S8vxjHusNmexxsB8N5-_888QNbN3Sb |
| CitedBy_id | crossref_primary_10_1128_JVI_80_8_3985_3993_2006 crossref_primary_10_1097_00001432_200406000_00005 crossref_primary_10_1002_eji_200838391 crossref_primary_10_1016_j_vaccine_2010_01_043 crossref_primary_10_3389_fimmu_2018_03123 crossref_primary_10_1371_journal_pone_0024018 crossref_primary_10_4049_jimmunol_173_10_5935 crossref_primary_10_1016_j_immuni_2007_06_006 crossref_primary_10_1128_JVI_00062_07 crossref_primary_10_1016_j_jri_2011_01_023 crossref_primary_10_1089_vim_2005_18_419 crossref_primary_10_4049_jimmunol_174_1_441 crossref_primary_10_1128_JVI_77_20_11082_11093_2003 crossref_primary_10_4049_jimmunol_172_2_1018 crossref_primary_10_1038_s41467_020_20659_2 crossref_primary_10_1002_eji_201041224 crossref_primary_10_1038_icb_2012_16 crossref_primary_10_1111_j_1365_3083_2007_01977_x crossref_primary_10_1371_journal_pone_0085302 crossref_primary_10_1016_j_cair_2003_10_001 crossref_primary_10_1016_j_clml_2020_10_014 crossref_primary_10_1128_IAI_00322_07 crossref_primary_10_1007_s11596_007_0117_y crossref_primary_10_1586_erv_11_196 crossref_primary_10_1038_nri_2017_54 crossref_primary_10_1128_IAI_74_4_1999_2006_2006 crossref_primary_10_4049_jimmunol_174_1_404 crossref_primary_10_4049_jimmunol_178_6_3695 crossref_primary_10_1128_JVI_78_18_10086_10095_2004 crossref_primary_10_1002_eji_200535759 crossref_primary_10_4049_jimmunol_172_10_6304 crossref_primary_10_3390_v1030383 crossref_primary_10_4049_jimmunol_172_9_5396 crossref_primary_10_1111_j_1365_2613_2008_00580_x crossref_primary_10_1371_journal_ppat_1003828 crossref_primary_10_1155_2013_369172 crossref_primary_10_1182_blood_2003_04_1200 crossref_primary_10_1016_j_intimp_2006_04_019 crossref_primary_10_1038_nri1394 crossref_primary_10_1002_eji_200324443 crossref_primary_10_1016_j_cyto_2018_06_004 crossref_primary_10_1111_j_1440_1711_2005_01392_x crossref_primary_10_1182_blood_2003_11_3789 crossref_primary_10_1186_1743_422X_2_59 crossref_primary_10_1186_1743_422X_2_56 crossref_primary_10_4049_jimmunol_180_5_3038 crossref_primary_10_1038_s41598_018_30631_2 crossref_primary_10_1093_cei_uxae048 crossref_primary_10_1084_jem_20062013 crossref_primary_10_1128_IAI_72_8_4637_4646_2004 crossref_primary_10_1164_rccm_200608_1068OC crossref_primary_10_1371_journal_ppat_1005561 crossref_primary_10_1128_JVI_01866_14 |
| ContentType | Journal Article |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1084/jem.20021900 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Medicine |
| ExternalDocumentID | 12615899 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GroupedDBID | --- -~X .55 .GJ 0VX 18M 29K 2WC 36B 3O- 4.4 53G 5GY 5RE 5VS 9M8 ABOCM ABZEH ACGFO ACNCT ACPRK ADBBV AENEX AFFNX AFOSN AFRAH AI. ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BTFSW C45 CGR CS3 CUY CVF D-I DIK DU5 E3Z EBS ECM EIF EJD EMB F5P F9R FRP GX1 H13 HYE H~9 IH2 K-O KQ8 L7B MVM N4W N9A NPM O5R O5S OHT OK1 P2P P6G R.V RHF RHI RPM SJN TR2 TRP UHB VH1 VXZ W8F WOQ X7M ZGI 7X8 |
| ID | FETCH-LOGICAL-c477t-78ed967c67a910e7345f19f367f9ce21e84475b387e1dcf2b9d05cb04aacb4c62 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 62 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000181411400005&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0022-1007 |
| IngestDate | Fri Sep 05 13:00:50 EDT 2025 Wed Feb 19 02:34:13 EST 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 5 |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c477t-78ed967c67a910e7345f19f367f9ce21e84475b387e1dcf2b9d05cb04aacb4c62 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC2193820 |
| PMID | 12615899 |
| PQID | 73071613 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_73071613 pubmed_primary_12615899 |
| PublicationCentury | 2000 |
| PublicationDate | 2003-Mar-03 20030303 |
| PublicationDateYYYYMMDD | 2003-03-03 |
| PublicationDate_xml | – month: 03 year: 2003 text: 2003-Mar-03 day: 03 |
| PublicationDecade | 2000 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | The Journal of experimental medicine |
| PublicationTitleAlternate | J Exp Med |
| PublicationYear | 2003 |
| SSID | ssj0014456 |
| Score | 1.9886717 |
| Snippet | Flt-3 ligand (FL), a hematopoetic growth factor, increases the number of dendritic cells (DCs), B cells, and natural killer cells in adult mice but the effect... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 575 |
| SubjectTerms | Animals Animals, Newborn B-Lymphocytes - metabolism Dendritic Cells - immunology Dendritic Cells - metabolism Flow Cytometry Herpes Simplex - immunology Herpesvirus 1, Human Homeodomain Proteins - genetics Homeodomain Proteins - metabolism Immunity, Innate Interferon-alpha - metabolism Interferon-beta - metabolism Interleukin-12 - metabolism Killer Cells, Natural - immunology Killer Cells, Natural - metabolism Listeria monocytogenes Listeriosis - immunology Membrane Proteins - pharmacology Mice Mice, Inbred Strains Mice, Knockout Skin - cytology Skin - metabolism Spleen - cytology Spleen - metabolism Survival Rate |
| Title | Flt3 ligand-treated neonatal mice have increased innate immunity against intracellular pathogens and efficiently control virus infections |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/12615899 https://www.proquest.com/docview/73071613 |
| Volume | 197 |
| WOSCitedRecordID | wos000181411400005&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NS8MwFA_TiXjx-2N-5uA1rG2ypAVBRBwe3NhBYbfxmqZamd1cu8H-BP9rX7IWT-JBKD0kpLQvr8kv7_3ee4RcqyAOJQ8MCzoATEDsM5BRzBQXHigpEqldoPCT6vfD4TAaNMhNHQtjaZX1mugW6mSirY28jZqI0N7nt9NPZmtGWd9qVUBjjTQ5Ahmr02r440MQwtVudXx1ywWoaO9eKNrv5mPFTog873do6baY7s7_Xm6XbFfQkt6tdGGPNEy-TzZ7lfP8gHx1xyWn4-wV8oQ5grlJaG6s-RyH2bL09A0Whma5RZIFdmY59mGDiyEplxReIUM4ie3lDKzJ33JYqS1qPEE9LCg-mBqXkwK3svGSVjx4ushm84LWvK-8OCQv3Yfn-0dWVWJgWihVMhWaJJJKSwUILwxOZCf1o5RLlUbaBL4Jbd7AmIfK-IlOgzhKvI6OPQGgY6FlcETW80luTgiFFCTgmYZ7xgieiNDjFqMGKbdB-X7cIle1iEeo6fZbAEUxL0a1kFvkeDVLo-kqIcfIx2NgBw-Op3-OPSNbjo3nrnPSTPEfNxdkQy_KrJhdOgXCe3_Q-wbYstOW |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Flt3+ligand-treated+neonatal+mice+have+increased+innate+immunity+against+intracellular+pathogens+and+efficiently+control+virus+infections&rft.jtitle=The+Journal+of+experimental+medicine&rft.au=Vollstedt%2C+Sabine&rft.au=Franchini%2C+Marco&rft.au=Hefti%2C+Hans+P&rft.au=Odermatt%2C+Bernhard&rft.date=2003-03-03&rft.issn=0022-1007&rft.volume=197&rft.issue=5&rft.spage=575&rft_id=info:doi/10.1084%2Fjem.20021900&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-1007&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-1007&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-1007&client=summon |